2Seventy Bio Inc Total Liabilities

Latest as of March 2025: $266.04 Million USD

2Seventy Bio Inc total liabilities. Based on the latest financial reports, 2Seventy Bio Inc (TSVT) has total liabilities worth $266.04 Million USD as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check TSVT cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of 2Seventy Bio Inc (2019–2024)

Total liabilities of 2Seventy Bio Inc from 2019 to 2024. This chart illustrates how 2Seventy Bio Inc's total liabilities have evolved over time, based on quarterly financial data. Explore 2Seventy Bio Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.

2Seventy Bio Inc Competitors by Total Liabilities

The table below lists competitors of 2Seventy Bio Inc ranked by their total liabilities.

Company Country Total Liabilities
Vox Royalty Corp.
TO:VOXR
Canada CA$10.30 Million
Beijing Sanfo Outdoor Products Co Ltd
SHE:002780
China CN¥536.05 Million
Zhejiang Golden Eagle Co Ltd
SHG:600232
China CN¥910.56 Million
Panama Petrochem Limited
NSE:PANAMAPET
India Rs4.50 Billion
Taeyoung Engineering & Construction Co.,Ltd.
KO:009415
Korea ₩3.15 Trillion
Kenmare Resources PLC
IR:KMR
Ireland €189.04 Million
SuRo Capital Corp
NASDAQ:SSSS
USA $71.71 Trillion
Harbin Air Conditioning Co Ltd
SHG:600202
China CN¥1.91 Billion

Liability Composition Analysis (2019–2024)

This chart breaks down 2Seventy Bio Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 2Seventy Bio Inc balance sheet assets.

Liquidity & Leverage Metrics

2Seventy Bio Inc Total Liabilities Ratios Explained

2Seventy Bio Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 4.80 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.24 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.55 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how 2Seventy Bio Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for 2Seventy Bio Inc (2019–2024)

The table below shows the annual total liabilities of 2Seventy Bio Inc from 2019 to 2024.

Year Total Liabilities Change
2024-12-31 $268.70 Million -13.36%
2023-12-31 $310.13 Million -10.42%
2022-12-31 $346.20 Million -13.42%
2021-12-31 $399.85 Million +68.01%
2020-12-31 $237.99 Million -12.26%
2019-12-31 $271.26 Million --

About 2Seventy Bio Inc

NASDAQ:TSVT USA Biotechnology
Market Cap
$266.14 Million
Market Cap Rank
#14763 Global
#3562 in USA
Share Price
$5.00
Change (1 day)
+0.00%
52-Week Range
$5.00 - $5.00
All Time High
$42.56
About

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes Abecma, a chimeric antigen receptor T-cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol Myers Squibb Company. 2seventy bio, Inc. was inco… Read more